Standard BioTools Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $120.9M | $166.7M | $51.7M | $81.3M | $28.5M | $68.5M | $21.7M | $95.4M |
| Accounts Receivable | $13.4M | $14.7M | $19.7M | $17.3M | $18.3M | $25.4M | $19.0M | $16.7M |
| Inventory | $20.0M | $20.7M | $20.5M | $21.5M | $20.8M | $19.7M | $13.9M | $13.0M |
| Total Current Assets | $454.3M | $375.9M | $158.2M | $208.8M | $72.1M | $117.7M | $96.1M | $127.1M |
| Property, Plant & Equipment | $19.3M | $22.8M | $24.2M | $25.7M | $28.0M | $17.5M | $8.1M | $8.8M |
| Goodwill | — | $111.3M | $106.3M | $106.3M | $106.4M | $106.6M | $104.1M | $104.1M |
| Intangible Assets (Excl. Goodwill) | — | $29.0M | $1.4M | $12.6M | $27.9M | $40.2M | $46.2M | $57.4M |
| Total Assets | $567.8M | $612.3M | $323.1M | $390.3M | $275.2M | $324.8M | $264.8M | $303.6M |
| Liabilities | ||||||||
| Accounts Payable | $5.4M | $5.0M | $9.2M | $7.9M | $10.6M | $9.2M | $5.2M | $4.0M |
| Total Current Liabilities | $108.3M | $65.9M | $109.3M | $43.4M | $49.6M | $54.2M | $32.8M | $37.6M |
| Long-Term Debt | — | $299.0K | $63.5M | $64.9M | — | — | — | — |
| Total Liabilities | $143.5M | $140.6M | $159.9M | $160.5M | $180.6M | $185.7M | $111.2M | $231.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.26B | $-1.19B | $-1.00B | $-926.1M | $-736.0M | $-676.8M | $-623.6M | $-558.9M |
| Total Stockholders' Equity | $424.3M | $471.7M | $-148.1M | $-81.5M | $94.6M | $139.1M | $153.6M | $72.1M |